Products

XYLENE®

XYLOMETAZOLINE
XYLENE®

Available Presentations:

  • NASAL DROPS, 10 mL, 0.1%
  • NASAL DROPS, 10 mL, 0.05%
  • NASAL SPRAY, 10 mL, 0.1%
  • NASAL SPRAY, 10 mL, 0.05%
  • NASAL SPRAY, 15 ML, 0.1%
  • NASAL SPRAY, 15 ML, 0.05%
  • ACTIVE NASAL SPRAY, 15 ML, 0.1%
  • NEO NASAL SPRAY, 15 G, 0.1%
Xylometazoline-based vasoconstrictor. For treatment of rhinites (coryza).

INN: xylometazoline

Pharmacotherapeutic group: anti-cold drug, alpha-adrenomimetic

Presentation:

– Nasal drops, 10 ml, 0.1%
– Nasal drops, 10 ml, 0.05%
– Nasal spray, 10 ml, 0.1%
– Nasal spray, 10 ml, 0.05%
– Nasal spray, 15 ml, 0.1%
– Nasal spray, 15 ml, 0.05%
– Active nasal spray, 15 ml, 0.1%
– NEO nasal spray, 15 g, 0.1%

Authorization Number:

P N002372/01 of 31 March 2008 (nasal drops)
LP – 000748 of 29 September 2011 (nasal spray)
LP - 003492 of 9 March 2016 (active nasal spray)
LP - 004832 of 3 May 2018 (NEO nasal spray)

ATC Code: R01AA07
Dispensing Rules: over-the-counter

For complete information, see the Label.

Download PDF


THE INFORMATION ON THIS PAGE IS NOT AN ADVERTISEMENT AND IS INTENDED TO INFORM ON THE PRODUCTS MANUFACTURED BY THE COMPANY.

THE MEDICINAL PRODUCTS HAVE CONTRAINDICATIONS, CONTACT YOUR DOCTOR.